Overall rank by patents
#28,444
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 23 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS).
The verdict
Cellutech holds 9 US patents across 23 technology areas, rank #28,444 of 50,000 tracked assignees.
Cellutech AB has been granted 9 US utility patents between 2015 and 2023, placing Cellutech AB at rank #28,444 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS). As a Foreign Corporation, Cellutech AB is one of the more focused assignees in the PatentsView dataset. By volume, Cellutech sits between Celeno Communications Ltd. (9 patents, rank #28,440) and Certona Corporation (9 patents, rank #28,448) - the closest US assignees by grant volume. The composite Innovation Score of 38.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 6 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cellutech AB's 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cellutech AB against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Celeno Communications Ltd.
9 patents
Cell Medica, Inc.
9 patents
Cellino Biotech, Inc.
9 patents
Cellsec, Inc.
9 patents
Center Vue S.p.A.
9 patents
Central Adelaide Local Health Network Incorporated
9 patents
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV)
9 patents
Certona Corporation
9 patents
Cellutech AB
9 patents
What this shows Cellutech holds 9 patents at rank #28,444, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,444 in granted patent volume.
Other assignees with the most granted patents in Cellutech's primary technology class.
Cellutech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 11.1% |
| 2017 | 3 | 33.3% |
| 2018 | 2 | 22.2% |
| 2021 | 2 | 22.2% |
| 2023 | 1 | 11.1% |
Top 15 of 23 technology areas
Overall rank by patents
#28,444
Across all tracked assignees
38.6 out of 100
How to use this portfolio
Cellutech's 9 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.